Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Placing and Subscription to raise up to £25 million, Open Offer to raise up to £4.2 million and Notice of General Meeting

26 Feb 2021

Shield Therapeutics plc, announces a proposed fundraising by way of a subscription (the “Subscription”) and placing (the “Placing“) to raise up to £25.0 million in aggregate at a price per share of 30.0 pence (the “Issue Price“). The Company also announces it will be making an Open Offer to Qualifying Shareholders at the Issue Price to raise up to £4.2 million (the “Open Offer“, and together with the Subscription and the Placing, the “Fundraising“).  For more information click here.

Back to news